Plasma von Willebrand factor (vWF) is a multimeric protein that mediates adhesion of platelets to sites of vascular injury. Only the very large vWF multimers are effective in promoting platelet adhesion in flowing blood. A protein disulfide bond reductase in plasma reduces the average multimer size of vWF secreted by endothelial cells. This activity has been isolated from human endothelial cell conditioned medium and shown to be the trimeric glycoprotein, thrombospondin-1 (TSP-1). Incubation of purified TSP-1 with vWF resulted in formation of thiol-dependent complexes of TSP-1 and vWF, generation of new thiols in vWF, and reduction in the average multimer size of vWF. The ratio of the concentrations of TSP-1 and vWF in plasma reflected with average multimer size of vWF. The higher the plasma TSP-1/vWF molar ratio, the smaller the average vWF multimer size. In addition, administration of TSP-1 to mice resulted in reduction in the average multimer size of plasma vWF. Interaction of TSP-1 with vWF is mediated by TSP-1 type 1 properdin domains and the vWF A3 domain. These results indicate that TSP-1 regulates the multimeric size and therefore hemostatic activity of vWF.
Skip Nav Destination
Article navigation
18 June 2001
Article|
June 11 2001
Control of Von Willebrand Factor Multimer Size by Thrombospondin-1
Lijuan Xie,
Lijuan Xie
aCentre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia
Search for other works by this author on:
Colin N. Chesterman,
Colin N. Chesterman
aCentre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia
Search for other works by this author on:
Philip J. Hogg
Philip J. Hogg
aCentre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia
Search for other works by this author on:
Lijuan Xie
aCentre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia
Colin N. Chesterman
aCentre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia
Philip J. Hogg
aCentre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales and Department of Haematology, Prince of Wales Hospital, Sydney, NSW 2052, Australia
Abbreviations used in this paper: GSH, reduced glutathione; MPB, 3-(N-maleimidylpropionyl)biocytin; NEM, N-ethylmaleimide; PVDF, polyvinylidine difluoride; TSP-1, thrombospondin-1; TTP, thrombotic thrombocytopenic purpura; vWF, von Willebrand factor.
Received:
November 13 2000
Revision Requested:
March 19 2001
Accepted:
April 26 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 193 (12): 1341–1350.
Article history
Received:
November 13 2000
Revision Requested:
March 19 2001
Accepted:
April 26 2001
Citation
Lijuan Xie, Colin N. Chesterman, Philip J. Hogg; Control of Von Willebrand Factor Multimer Size by Thrombospondin-1. J Exp Med 18 June 2001; 193 (12): 1341–1350. doi: https://doi.org/10.1084/jem.193.12.1341
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement